EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Chandra Bhagat Pharma's enterprise value is ₹1,073 Mil.
Chandra Bhagat Pharma's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹38 Mil. Therefore, Chandra Bhagat Pharma's EV-to-EBITDA for today is 28.03.
The historical rank and industry rank for Chandra Bhagat Pharma's EV-to-EBITDA or its related term are showing as below:
BOM:542934'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.38 Med: 23.76 Max: 35.93
Current: 28.03
During the past 7 years, the highest EV-to-EBITDA of Chandra Bhagat Pharma was 35.93. The lowest was 12.38. And the median was 23.76.
BOM:542934's EV-to-EBITDA is ranked worse than 80.85% of 705
companies
in the Drug Manufacturers industry
Industry Median: 14.58
vs BOM:542934: 28.03
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Chandra Bhagat Pharma EV-to-EBITDA Historical Data
The historical data trend for Chandra Bhagat Pharma's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Chandra Bhagat Pharma's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Chandra Bhagat Pharma's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandra Bhagat Pharma's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chandra Bhagat Pharma's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Chandra Bhagat Pharma's EV-to-EBITDA falls into.
Chandra Bhagat Pharma's current Enterprise Value is ₹1,073 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Chandra Bhagat Pharma's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹38 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Chandra Bhagat Pharma's PE Ratio for today is calculated as:
Chandra Bhagat Pharma's share price for today is ₹120.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Chandra Bhagat Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹1.550.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Chandra Bhagat Pharma's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Chandra Bhagat Pharma (BOM:542934) Business Description
Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:542934 has been successfully added to your 